RATIONAL DESIGN OF POTENT, BIOAVAILABLE NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS

被引:0
|
作者
ERICKSONVIITANEN, S
LAM, PYS
JADHAV, PK
EYERMANN, CJ
HODGE, CN
RU, Y
BACHELER, LT
MEEK, JL
OTTO, MJ
RAYNER, MM
WONG, YN
CHANG, CH
WEBER, PC
JACKSON, DA
SHARPE, TR
机构
[1] DUPONT MERCK PHARMACEUT CO,DEPT VIROL RES,WILMINGTON,DE 19880
[2] DUPONT MERCK PHARMACEUT CO,DEPT CHEM & PHYS SCI,WILMINGTON,DE 19880
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:167 / 167
页数:1
相关论文
共 50 条
  • [1] RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
    LAM, PYS
    JADHAV, PK
    EYERMANN, CJ
    HODGE, CN
    RU, Y
    BACHELER, LT
    MEEK, JL
    OTTO, MJ
    RAYNER, MM
    WONG, YN
    CHANG, CH
    WEBER, PC
    JACKSON, DA
    SHARPE, TR
    ERICKSONVIITANEN, S
    SCIENCE, 1994, 263 (5145) : 380 - 384
  • [2] DE-NOVO DESIGN OF POTENT NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
    LAM, PYS
    EYERMANN, CJ
    JADHAV, PK
    HODGE, CN
    RU, Y
    BACHELER, LT
    MEEK, JL
    OTTO, MJ
    RAYNER, MM
    WONG, NY
    CHANG, CH
    WEBER, PC
    JACKSON, DA
    SHARPE, TR
    ERICKSONVIITANEN, SK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 88 - COMP
  • [3] A PRACTICAL SYNTHESIS OF NONPEPTIDE CYCLIC UREAS AS POTENT HIV PROTEASE INHIBITORS
    ROSSANO, LT
    LO, YS
    ANZALONE, L
    LEE, YC
    MELONI, DJ
    MOORE, JR
    GALE, TM
    ARNETT, JF
    TETRAHEDRON LETTERS, 1995, 36 (28) : 4967 - 4970
  • [4] A practical synthesis of nonpeptide cyclic ureas as potent HIV protease inhibitors
    Rossano, L. T.
    Lo, Y. S.
    Anzalone, L.
    Lee, Y.-C.
    Tetrahedron Letters, 36 (28):
  • [5] RATIONAL DESIGN OF POTENT NONPEPTIDAL HIV PROTEASE INHIBITORS
    GHOSH, AK
    CHEN, Y
    XU, YB
    CHO, WH
    BUTHOD, J
    HOLLAND, LE
    WALTERS, DE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 27 - MEDI
  • [6] COMPUTER-ASSISTED DESIGN OF POTENT NONPEPTIDE INHIBITORS OF HIV PROTEASE
    JADHAV, PK
    LAM, PY
    EYERMANN, CJ
    HODGE, CN
    WOERNER, FJ
    BACHELER, LT
    MEEK, UL
    OTTO, MJ
    RAYNER, MM
    WONG, NY
    CHANG, CH
    WEBER, PC
    JACKSON, DA
    SHARPE, TR
    ERICKSONVIITANEN, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 107 - MEDI
  • [7] NOVEL AZA-CYCLIC UREAS THAT ARE POTENT INHIBITORS OF HIV PROTEASE .2.
    STEWART, KD
    PARK, CH
    KONG, XP
    SHAM, HL
    ZHAO, C
    HERRIN, T
    BETEBENNER, DA
    ROSENBROOK, W
    MADIGAN, D
    LIN, SQ
    SALDIVAR, A
    WIDEBURG, NE
    KEMPF, DJ
    NORBECK, DW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 8 - MEDI
  • [8] DESIGN AND SYNTHESIS OF POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS
    KALDOR, SW
    KALISH, V
    DRESSMAN, BA
    FRITZ, JE
    HAMMOND, M
    CROWELL, TA
    TATLOCK, J
    REICH, S
    DAVIES, J
    APPELT, K
    SHETTY, B
    SU, KS
    CAMPANALE, KM
    BURGESS, JA
    LUBBENHUSEN, PP
    BAXTER, AJ
    MUESING, MA
    HATCH, SD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 17 - MEDI
  • [9] Cyclic HIV protease inhibitors:: Design and synthesis of orally bioavailable, pyrazole P2/P2′ cyclic ureas with improved potency
    Han, Q
    Chang, CH
    Li, RH
    Ru, Y
    Jadhav, PK
    Lam, PYS
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) : 2019 - 2028
  • [10] From nonpeptide toward noncarbon protease inhibitors:: Metallacarboranes as specific and potent inhibitors of HIV protease
    Cígler, P
    Kozísek, M
    Rezácová, P
    Brynda, J
    Otwinowski, Z
    Pokorná, J
    Plesek, J
    Grüner, B
    Dolecková-Maresová, L
    Mása, M
    Sedlácek, J
    Bodem, J
    Kräusslich, HG
    Král, V
    Konvalinka, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) : 15394 - 15399